Brief: Aclaris Therapeutics Announces Patent License Agreement With Sun Pharma For Alopecia

Aclaris Therapeutics

05/12/2023 21:05

Dec 6 (Reuters) - Aclaris Therapeutics Inc  ACRS.O :
    * ACLARIS THERAPEUTICS ANNOUNCES PATENT LICENSE AGREEMENT
WITH SUN
PHARMA FOR ALOPECIA
    * ACLARIS THERAPEUTICS : CO GRANTED SUN PHARMA EXCLUSIVE
RIGHTS
UNDER CERTAIN PATENTS FOR USE OF DEURUXOLITINIB OR OTHER
ISOTOPIC FORMS OF RUXOLITINIB
    * ACLARIS THERAPEUTICS INC: AGREEMENT INCLUDES AN UPFRONT
PAYMENT
OF $15 MILLION, REGULATORY AND COMMERCIAL MILESTONES, AND
ROYALTIES

Source text for Eikon:  ID:nGNX3K2DHv 
Further company coverage:  ACRS.O 

 ((Reuters.Briefs@thomsonreuters.com))